Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: A test utilization study

American Journal of Clinical Pathology

Volumn 138, Issue 2, 2012, Pages 262-272

  Greene, Dina N ^a,b   Schmidt, Robert L ^b   Wilson, Andrew R ^c   Freedman, Mark S ^d   Grenache, David G ^b,c  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b ARUP LABORATORIES   (United States)

^c ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Biomarkers; CSF analysis; IgG index; Multiple sclerosis; Myelin basic protein; Oligoclonal bands; Sensitivity and specificity; Test utilization

Indexed keywords

IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; OLIGOCLONAL BAND;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UNNECESSARY PROCEDURES;

EID: 84865442472     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPCYCH96QYPHJM     Document Type: Article

References (34)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-1231. (Pubitemid 34304266)
2. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231. (Pubitemid 13158528)
3. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
4. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol. 2005;58:840-846. (Pubitemid 41746873)
5. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292-302.
6. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multi Scler. 2008;14:1157-1174.
7. Awad A, Hemmer B, Hartung HP, et al. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol 2010;219:1-7.
8. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005;62:865-870. (Pubitemid 40973448)
9. Bourahoui A, De Seze J, Guttierez R, et al. CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol. 2004;11:525-529. (Pubitemid 39062090)
10. Fortini AS, Sanders EL, Weinshenker BG, et al. Cerebrospinal fluid oligoclonal bands in the diagnosis of multiple sclerosis: isoelectric focusing with IgG immunoblotting compared with high-resolution agarose gel electrophoresis and cerebrospinal fluid IgG index. Am J Clin Pathol. 2003;120:672-675. (Pubitemid 37339672)
11. Whitaker JN, Lisak RP, Bashir RM, et al. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol 1980;7:58-64. (Pubitemid 10129570)
12. Whitaker JN. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology. 1977;27:911-920. (Pubitemid 8207162)
13. Tian ZJ, Zhao XX, Li ZH, et al. Evaluation of myelin basic protein levels with receiver operating characteristic curves for diagnosis of multiple sclerosis [in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29:250-252.
14. Cerri CG, Silani V, Scarlato G. Oligoclonal immunoglobulins and immunoreactive myelin basic protein in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Acta Neurol (Napoli). 1985;7:311-314. (Pubitemid 15236163)
15. Lamers KJ, de Reus HP, Jongen PJ. Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis. Multi Scler 1998;4:124-126. (Pubitemid 28410036)
16. Ohta M, Ohta K, Ma J, et al. Clinical and analytical evaluation of an enzyme immunoassay for myelin basic protein in cerebrospinal fluid. Clin Chem. 2000;46:1326-1330.
17. Whitaker JN. Myelin basic protein in cerebrospinal fluid and other body fluids. Multi Scler 1998;4:16-21. (Pubitemid 28077431)
18. Cohen SR, Brooks BR, Herndon RM, et al. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann Neurol. 1980;8:25-31. (Pubitemid 10056346)
19. Gerson B, Cohen SR, Gerson IM, et al. Myelin basic protein, oligoclonal bands, and IgG in cerebrospinal fluid as indicators of multiple sclerosis. Clin Chem. 1981;27:1974-1977. (Pubitemid 12194422)
20. Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiology. 2007;29:150-155. (Pubitemid 351197516)
21. Kostulas VK, Link H, Lefvert AK. Oligoclonal IgG bands in cerebrospinal fluid. Principles for demonstration and interpretation based on findings in 1114 neurological patients. Arch Neurol 1987;44:1041-1044.
22. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index: a comparison and diagnostic applications. Brain. 1990;113(Pt 5):1269-1289. (Pubitemid 20385912)
23. Beer S, Rosler KM, Hess CW. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry. 1995;59:152-159.
24. Paolino E, Fainardi E, Ruppi P, et al. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996;60:572-575. (Pubitemid 26147901)
25. Barry R, Payton M, Groome N. Characterization of myelin basic protein catabolism products in the cerebrospinal fluid from multiple sclerosis, stroke and head injury patients. Neurochem Int. 1991;18:291-300.
26. Glynn P, Chantry A, Groome N, et al. Basic protein dissociating from myelin membranes at physiological ionic strength and pH is cleaved into three major fragments. J Neurochem. 1987;48:752-759. (Pubitemid 17018705)
27. Chou CH, Tourtellotte WW, Kibler RF. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology. 1983;33:24-28. (Pubitemid 13171153)
28. Barry R, Lawrence M, Thompson A, et al. An improved radioimmunoassay for myelin basic protein-like immunoreactive material in cerebrospinal fluid. Neurochem Int. 1990;16:549-558. (Pubitemid 20221683)
29. Karlsson B, Alling C. Molecular size of myelin basic protein immunoactivity in spinal fluid. J Neuroimmunol 1984;6:141-150. (Pubitemid 14101478)
30. Chamczuk AJ, Ursell M, O'Connor P, et al. A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. J Immunol Methods. 2002;262:21-27. (Pubitemid 34450727)
31. Warren KG, Catz I. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis. Ann Neurol. 1986;20:20-25. (Pubitemid 16063231)
32. Pesce AJ, Apple R, Sawtell N, et al. Cationic antigens: problems associated with measurement by ELISA. J Immunol Methods. 1986;87:21-27. (Pubitemid 16189006)
33. Warren KG, Catz I, McPherson TA. CSF myelin basic protein levels in acute optic neuritis and multiple sclerosis. Can J Neurol Sci 1983;10:235-238. (Pubitemid 14243106)
34. Cossburn M, Ingram G, Hirst C, et al. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multi Scler. 2012;18:45-54.